Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD

Clinical trial NCT04932980 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04932980
Sponsor: Berner Augenklinik
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Wet Age-related Macular Degeneration

Start date: 2022-05-09
Primary completion: 2027-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.